Plethico Pharmaceuticals Ltd Annually Results

Gross Sales

757.93

2,059.8

1,746.78

1,631.54

1,557.04

Excise Duty

0

0

0

0

0

Net Sales

757.93

2,059.8

1,746.78

1,631.54

1,557.04

Other Operating Income

7.2

38.63

39.93

22.14

84.3

Other Income

0

0

1.5

8.31

0.03

Total Income

765.13

2,098.43

1,788.2

1,662.01

1,641.38

Total Expenditure

971.34

1,778.03

1,516.3

1,473.56

1,408.05

PBIDT

-206.21

320.4

271.91

188.44

233.33

Interest

121.55

159.32

102.3

61.43

83.54

PBDT

-327.76

161.08

169.61

127.01

149.78

Depreciation

57.9

64.23

48.43

17.72

18.6

Minority Interest Before NP

0

0

0

0

0

Tax

-107.94

-13.84

-1.5

7.78

28.28

Deferred Tax

0

0

0

0

0

Reported Profit After Tax

-277.72

110.69

122.66

101.48

102.91

Minority Interest After NP

0

0

0

0

0

Net Profit after Minority Interest

-277.72

110.69

122.66

101.48

102.91

Extra-ordinary Items

-319.56

0

0

7.53

-63

Adjusted Profit After Extra-ordinary item

41.84

110.69

122.66

93.94

165.91

EPS (Unit Curr.)

-81.52

32.49

36

29.79

30.2

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

34.07

34.07

34.06

34.06

34.06

Public Shareholding (Number)

96,45,975

89,65,737

78,55,737

58,92,622

44,26,667

Public Shareholding (%)

28.31

26.32

23.05

17.29

12.98

Pledged/Encumbered - No. of Shares

2,09,37,385

2,16,21,885

2,27,31,884

2,75,64,950

2,78,46,050

Pledged/Encumbered - % in Total Promoters Holding

85.74

86.14

86.73

97.83

93.94

Pledged/Encumbered - % in Total Equity

61.46

63.47

66.73

80.91

81.73

Non Encumbered - No. of Shares

34,83,307

34,79,045

34,79,045

6,09,095

17,93,950

Non Encumbered - % in Total Promoters Holding

14.26

13.86

13.27

2.16

6.05

Non Encumbered - % in Total Equity

10.22

10.21

10.21

1.78

5.26

PBIDTM(%)

-27.2

15.55

15.56

11.54

14.98

PBDTM(%)

-43.24

7.82

9.7

7.78

9.62

PATM(%)

-36.64

5.37

7.02

6.22

6.6